Merck & Co., Inc.
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 64.2B 60.1B 59.3B 48.7B
Cost of revenue 15.2B 16.1B 17.4B 13.6B
Gross profit 49.0B 44.0B 41.9B 35.1B
Operating expense
Research & development 17.9B 30.5B 13.5B 12.2B
Selling general and admin 10.8B 10.5B 10.0B 9.6B
Other operating expenses
Operating income 20.2B 3.0B 18.3B 13.2B
Non operating interest income
Income 415M 365M 157M 36M
Expense 1.3B 1.1B 962M 806M
Other income expense 571M -284M -1.0B 1.5B
Pretax income 19.9B 1.9B 16.4B 13.9B
Tax provision 2.8B 1.5B 1.9B 1.5B
Net income 17.1B 377M 14.5B 12.4B
Basic EPS 6.8 0.1 5.7 5.2
Diluted EPS 6.7 0.1 5.7 5.1
Basic average shares 2.5B 2.6B 2.5B 2.5B
Diluted average shares 2.5B 2.6B 2.5B 2.5B
EBITDA 26.2B 7.5B 23.3B 16.9B
Net income from continuing op. 17.1B 377M 14.5B 12.4B
Minority interests -16M -12M -7M 691M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 3 hours 43 minutes

05:46
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).